Analyst Ratings for Iterum Therapeutics (ITRM)
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
N/A
Rating Score: 3.3 / 10
Percentile Rank: 28%

Rating Score: 3.3 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
7/27/2021 | Gabelli | Kevin Kedra | Upgrade | Hold (Sell) |
N/A (N/A) |
0.63 (0.20) |
-68.25% | Details |
7/26/2021 | H.C. Wainwright | Ed Arce | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.13 (0.20) |
-82.3% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |